These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8846659

  • 21. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C, Riis BJ, Pødenphant J, Christiansen C.
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [Abstract] [Full Text] [Related]

  • 22. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment.
    Huang RY, Miller LM, Carlson CS, Chance MR.
    Bone; 2002 Mar; 30(3):492-7. PubMed ID: 11882463
    [Abstract] [Full Text] [Related]

  • 23. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M, Saraf ML.
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract] [Full Text] [Related]

  • 24. Anabolic steroids and osteoporosis.
    Dequeker J, Geusens P.
    Acta Endocrinol Suppl (Copenh); 1985 Jun; 271():45-52. PubMed ID: 3865481
    [No Abstract] [Full Text] [Related]

  • 25. The effects of nandrolone decanoate on rarefying bone tissue.
    Dhem A, Ars-Piret N, Waterschoot MP.
    Curr Med Res Opin; 1980 Jun; 6(9):606-13. PubMed ID: 7408528
    [Abstract] [Full Text] [Related]

  • 26. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
    Aerssens J, Van Audekercke R, Geusens P, Schot LP, Osman AA, Dequeker J.
    Calcif Tissue Int; 1993 Oct; 53(4):269-77. PubMed ID: 8275356
    [Abstract] [Full Text] [Related]

  • 27. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.
    Adami S, Fossaluzza V, Rossini M, Bertoldo F, Gatti D, Zamberlan N, Lo Cascio V.
    Bone Miner; 1991 Oct; 15(1):73-81. PubMed ID: 1747568
    [Abstract] [Full Text] [Related]

  • 28. [Effect of anabolic steroids on osteoporosis].
    Adachi M, Takayanagi R.
    Clin Calcium; 2008 Oct; 18(10):1451-9. PubMed ID: 18830042
    [Abstract] [Full Text] [Related]

  • 29. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
    Hassager C, Jensen LT, Johansen JS, Riis BJ, Melkko J, Pødenphant J, Risteli L, Christiansen C, Risteli J.
    Metabolism; 1991 Feb; 40(2):205-8. PubMed ID: 1988778
    [Abstract] [Full Text] [Related]

  • 30. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
    Gerritsma EJ, Brocaar MP, Hakkesteegt MM, Birkenhäger JC.
    Clin Otolaryngol Allied Sci; 1994 Feb; 19(1):79-84. PubMed ID: 8174308
    [Abstract] [Full Text] [Related]

  • 31. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP, Androulakis C, Magiasis B, Charalambaki Z, Tsakalakos N.
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [Abstract] [Full Text] [Related]

  • 32. Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women.
    Hassager C, Pødenphant J, Riis BJ, Johansen JS, Jensen J, Christiansen C.
    Metabolism; 1989 Mar; 38(3):238-42. PubMed ID: 2645503
    [Abstract] [Full Text] [Related]

  • 33. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT, Herrold J, Ali I, Oktay E, Chlebowski JS, Ponce AT, Heber D, Block JB.
    Cancer; 1986 Jul 01; 58(1):183-6. PubMed ID: 3518910
    [Abstract] [Full Text] [Related]

  • 34. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
    Erdtsieck RJ, Pols HA, van Kuijk C, Birkenhäger-Frenkel DH, Zeelenberg J, Kooy PP, Mulder P, Birkenhäger JC.
    J Bone Miner Res; 1994 Feb 01; 9(2):277-83. PubMed ID: 8140941
    [Abstract] [Full Text] [Related]

  • 35. Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis.
    Need AG, Chatterton BE, Walker CJ, Steurer TA, Horowitz M, Nordin BE.
    Maturitas; 1986 Dec 01; 8(4):275-80. PubMed ID: 3574140
    [Abstract] [Full Text] [Related]

  • 36. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
    Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, Martinez C, Briggs W, Horton R, Azen S.
    J Clin Endocrinol Metab; 1999 Apr 01; 84(4):1268-76. PubMed ID: 10199766
    [Abstract] [Full Text] [Related]

  • 37. [Possibilities for pharmacological correction of regional osteoporosis in an unsupported extremity].
    Rogacheva IV, Poliakov AN, Volozhin AI, Stupakov GP.
    Kosm Biol Aviakosm Med; 1986 Apr 01; 20(6):47-51. PubMed ID: 3807300
    [Abstract] [Full Text] [Related]

  • 38. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C, Macía ML, García J, Navarro JF.
    Perit Dial Int; 2001 Apr 01; 21(6):611-4. PubMed ID: 11783772
    [No Abstract] [Full Text] [Related]

  • 39. Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis.
    Robin JC, Suh OW, Ambrus JL.
    Steroids; 1982 Aug 01; 40(2):125-32. PubMed ID: 7157449
    [Abstract] [Full Text] [Related]

  • 40. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL, Mulligan K, Schambelan M.
    JAMA; 1999 Apr 14; 281(14):1275-81. PubMed ID: 10208142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.